Back to last page

Reviewed by the Faculty of Harvard Medical School
Rhabdomyosarcoma
  • What Is It?
  • Symptoms
  • Diagnosis
  • Expected Duration
  • Prevention
  • Treatment
  • When To Call a Professional
  • Prognosis
  • Additional Info
  • What Is It?

    Rhabdomyosarcoma is a rare cancer seen in children more than adults. In about two-thirds of cases, rhabdomyosarcoma occurs in a child younger than 10. It is a soft tissue tumor that typically appears in one of three locations: the head and neck region (35% to 40% of cases), the urinary tract and reproductive organs (25% of cases), or the arms and legs (10% of cases). It also can occur on the trunk. Doctors classify this cancer based on the way the cells appear under a microscope; most are either embryonal (60% of cases) or alveolar (20% of cases).

    Rhabdomyosarcoma is often associated with specific genetic abnormalities. Certain people may be prone to developing this type of cancer, as part of an increased susceptibility to developing multiple cancers.

    In the United States, rhabdomyosarcoma strikes approximately 5 in every 1 million children each year. Children are more likely to develop rhabdomyosarcoma if they already have Li-Fraumeni syndrome or neurofibromatosis (type I), or if they have an older relative who has been diagnosed with early-onset breast cancer or adrenal cancer. Rhabdomyosarcoma is more common in children whose parents have used recreational drugs, especially marijuana or cocaine, and whose fathers smoke, but this association needs further study. Likewise, children of mothers who were exposed to multiple courses of antibiotics during pregnancy have also been associated with a high incidence of rhabdomyosarcomas.

    Symptoms

    Symptoms depend on where the tumor develops:

    Diagnosis

    After reviewing your child's symptoms, your doctor will examine your child. Depending on the results of this exam, your doctor may order a regular X-ray as the first test. Computed tomography (CT) scans and magnetic resonance imaging (MRI) might also be needed. If a tumor is found on any of these studies, small piece of tissue is removed and examined in a laboratory (biopsy).

    If the lab tests show signs of a cancerous (malignant) tumor, your doctor will refer you to a medical center that has the facilities, personnel and experience to treat childhood cancer. There your child will have more tests, which probably will include a chest X-ray, a chest CT scan, a radionuclide bone scan, a bone marrow biopsy and other tests to check whether the cancer has spread to the lungs, bones or elsewhere.

    Rhabdomyosarcomas are rare, and they can cause symptoms similar to more common conditions, such as bladder infections, sinusitis or sports injuries. For this reason, your doctor may not suspect cancer at first. In fact, in many cases, several months pass before the correct diagnosis is made.

    Expected Duration

    A rhabdomyosarcoma will continue to grow until it is treated. Without proper treatment, this cancer eventually may spread to the lungs, bone marrow, bones or lymph nodes.

    Prevention

    There is no way to prevent most cases of rhabdomyosarcoma. However, anyone who hopes to conceive a healthy child should avoid using recreational drugs and smoking tobacco. These dangerous chemicals could increase the risk of rhabdomyosarcoma or other medical conditions in the child, either at birth or later in life.

    Treatment

    The treatment of rhabdomyosarcoma is determined by two factors:

    Except for tumors located in the eye or genitourinary tract, the first step in treating most rhabdomyosarcoma is surgery. Surgery is followed by chemotherapy and radiation. For very large tumors, chemotherapy and radiation are given before surgery to shrink the tumor, so that the surgery will be less disfiguring.

    Surgery can be used after chemotherapy if there are residual amounts of tumor tissue left behind or abnormalities that are still persisting on X-ray examinations.

    In the eye, rhabdomyosarcoma usually is treated with radiation and chemotherapy, without surgery. For rhabdomyosarcoma in the bladder or female reproductive tract, chemotherapy and radiation are used to shrink the tumor before surgery. This allows the surgeon to preserve as much of the organ as possible.

    When To Call a Professional

    Call your doctor promptly if your child develops a persistent lump or swelling anywhere in the body, especially around the eye, on the face or neck, on an arm or leg, in the vagina or near a testicle. Also, call your doctor if your child has bloody urine, difficulty urinating, pain during urination or a persistent unexplained discharge from the nose, ear or vagina.

    Prognosis

    The outlook depends on the tumor group. With treatment, more than 80% of children with group 1 rhabdomyosarcoma survive disease-free. This percentage drops to about 50% for children in groups 2 and 3, and drops to less than 20% for children in group 4. In general, children with the embryonal variety of rhabdomyosarcoma respond better to treatment than those with the alveolar type. If rhabdomyosarcoma does not respond well to treatment, the child will die of the disease. It is important that the child visit a pediatric oncologist who can help coordinate the multiple treatments involved in managing this disease.

    Additional Info

    National Cancer Institute (NCI)
    NCI Public Inquiries Office
    6116 Executive Blvd.
    Room 3036A
    Bethesda, MD 20892-8322
    Toll-Free: 1-800-422-6237
    TTY: 1-800-332-8615
    http://www.nci.nih.gov/

    American Cancer Society (ACS)
    Toll-Free: 1-800-227-2345
    TTY: 1-866-228-4327
    http://www.cancer.org/

    American Academy of Pediatrics (AAP)
    141 Northwest Point Blvd.
    Elk Grove Village, IL 60007-1098
    Phone: 847-434-4000
    Fax: 847-434-8000
    Email: kidsdocs@aap.org
    http://www.aap.org/

    American Society of Clinical Oncology
    2318 Mill Road
    Suite 800
    Alexandria, VA 22314
    Phone: 571-483-1300
    Email: asco@asco.org
    http://www.asco.org/

    Last updated August 29, 2008